检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.

Pedro M Machado,Michael P McDermott,Thomas Blaettler,Claus Sundgreen,Anthony A Amato,Emma Ciafaloni,Miriam Freimer,Summer B Gibson,Sarah M Jones,Todd D Levine,Thomas E Lloyd,Tahseen Mozaffar,Aziz I Shaibani,Matthew Wicklund, Anders Rosholm, Tim Dehli Carstensen, Karen Bonefeld,Anders Nørkær Jørgensen,Karina Phonekeo,Andrew J Heim,Laura Herbelin,Richard J Barohn,Michael G Hanna,Mazen M Dimachkie

The Lancet. Neurology（2023）

引用 2|浏览12
暂无评分
摘要
US Food and Drug Administration Office of Orphan Products Development and Orphazyme.
更多
查看译文
关键词
inclusion body myositis,arimoclomol,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要